Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cholestyramine for Hyperphosphatemia in Hemodialysis
NCT05577507Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Mar 2023
- Primary completion
- May 2023
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of cholestyramine in hyperphosphatemia, sponsored by Ain Shams University. Started Mar 2023; status: completed.
02
Drugs
cholestyramine
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT05577507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05577507.